Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by BCL6 is a zinc finger transcription factor and contains an N-terminal POZ domain. Additionally we are shipping BCL6 Proteins (11) and BCL6 Kits (4) and many more products for this protein.
Showing 10 out of 158 products:
Human Monoclonal BCL6 Primary Antibody for IHC (p), ICS - ABIN967677
Baumjohann, Okada, Ansel: Cutting Edge: Distinct waves of BCL6 expression during T follicular helper cell development. in Journal of immunology (Baltimore, Md. : 1950) 2011
Show all 10 references for ABIN967677
Human Polyclonal BCL6 Primary Antibody for WB - ABIN656985
Chang, Vlad, DAgati, Liu, Zhang, Witkowski, Torkamani, Stokes, Ho, Cortesini, Suciu-Foca: BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 4 references for ABIN656985
Human Monoclonal BCL6 Primary Antibody for IF, WB - ABIN659194
Yang, Huang, Chatterjee, Twait, Fisher: A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. in The Journal of biological chemistry 2010
Show all 4 references for ABIN659194
Human Polyclonal BCL6 Primary Antibody for EIA, WB - ABIN950636
Lai, Fatemi, Dhasarathy, Malone, Sobol, Geigerman, Jaye, Mav, Shah, Li, Wade: DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. in The Journal of experimental medicine 2010
Show all 3 references for ABIN950636
Human Polyclonal BCL6 Primary Antibody for EIA, WB - ABIN1449999
Lee, Kim, Sivula, Strittmatter: Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2004
Show all 2 references for ABIN1449999
Human Polyclonal BCL6 Primary Antibody for ELISA, WB - ABIN1533156
Ye, Lista, Lo Coco, Knowles, Offit, Chaganti, Dalla-Favera: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. in Science (New York, N.Y.) 1993
Show all 2 references for ABIN1533156
Human Polyclonal BCL6 Primary Antibody for FACS, IHC (p) - ABIN391554
Saito, Novak, Piovan, Basso, Sumazin, Schneider, Crespo, Shen, Bhagat, Califano, Chadburn, Pasqualucci, Dalla-Favera: BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. in Proceedings of the National Academy of Sciences of the United States of America 2009
Show all 2 references for ABIN391554
Human Polyclonal BCL6 Primary Antibody for ELISA, WB - ABIN1532126
Miki, Kawamata, Hirosawa, Aoki: Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. in Blood 1994
Show all 2 references for ABIN1532126
BCL6 forms a complex with BCL6 corepressor (BCoR (show BCOR Antibodies)) on the promoters of selected Notch (show NOTCH1 Antibodies) target genes such as enhancer of split related 1.
synergistic activity of Card11 (show CARD11 Antibodies) mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model
Bcl6, by interacting with the co-factors NcoR2 (show NCOR2 Antibodies) and HDAC3 (show HDAC3 Antibodies), plays a pivotal role in controlling IRF7 (show IRF7 Antibodies) induction and antiviral signaling priming.
Bcl6 promoted T follicular helper cell differentiation through antagonizing IL-7R / STAT5a (show STAT5A Antibodies) axis.
Bob1 (show POU2AF1 Antibodies) directly binds to and transactivate the Bcl6 promoter during the development of follicular T helper cells .
upon binding to a composite NFAT (show NFATC1 Antibodies)/BCL6 regulatory element within the Ccl2 (show CCL2 Antibodies) promoter, NFATc1 (show NFATC1 Antibodies)/beta proteins release the BCL6-dependent repression of Ccl2 (show CCL2 Antibodies) gene in macrophages.
transferred Bcl6-deficient T cells into wildtype hosts. Bcl6-deficient T cells did not develop into GC Tfh, but they still generated CXCR5 (show CXCR5 Antibodies)+ IFN-gamma (show IFNG Antibodies)+ IL-21 (show IL21 Antibodies)+ IL-10 (show IL10 Antibodies)+ Teff, suggesting that this predominant population is not of the Tfh-lineage
Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3 (show MTA3 Antibodies).
Data indicate that signal transducer and activator of transcription 3 (Stat3 (show STAT3 Antibodies)) can repress the expression of transcription factor Bcl6 and interleukin-4 (IL-4 (show IL4 Antibodies)) in follicular helper T (TFH) cells.
Enforced expression of BCL6 in EGR2 (show EGR2 Antibodies)/3-deficient CD4 (show CD4 Antibodies) T cells partially restored Tfh differentiation and GC formation in response to virus infection
PRMT7 (show PRMT7 Antibodies) could recruit H4R3me1 and symmetric H4R3me2 to the Bcl6 promoter. These results provide evidence for the important roles played by PRMT7 (show PRMT7 Antibodies) in germinal center formation.
miR (show MLXIP Antibodies)-339-5p inhibits migration and invasion in ovarian cancer by targeting NACC1 (show NACC1 Antibodies) and BCL6. miR (show MLXIP Antibodies)-339-5p may be a biomarker of metastasis in ovarian cancer; NACC1 (show NACC1 Antibodies) had a predictive value for ovarian cancer progression
Data show there was a positive correlation between B cell lymphoma 6 (Bcl-6) and B lymphocyte-induced maturation protein 1 (Blimp-1 (show PRDM1 Antibodies)) at the level of mRNA.
miR (show MLXIP Antibodies)-155 overexpression plays a promoting role in the proliferative, migratory and invasive behavior of OSCC cells. Its effects on OSCC are possibly associated with its regulation of the BCL6/cyclin D2 (show CCND2 Antibodies) axis.
BCL6 Rearrangements are associated with Diffuse Large B-Cell Lymphoma.
diffuse large B-cell lymphoma patients with either MYC (show MYC Antibodies)/BCL6 rearrangements or MYC (show MYC Antibodies)/BCL6 co-expression did not always have poorer prognosis
BCL6 promotes proliferation and survival of trophoblastic cells.
Studies indicate that germinal centers (GC) B (show NPR2 Antibodies) cells represent the normal counterpart of most B-cell lymphomas, which are often characterized by deregulated B cell lymphoma 6 (BCL6) expression or BCL6-mediated pathways.
Bcl-6 mRNA and protein levels, as well as the frequencies of Bcl-6(+)CD4 (show CD4 Antibodies)(+) cells were significantly increased in polyp tissues compared with normal controls.
Follicular helper T cells differentiation is a multistage process involving BCL6 and other transcription factors, cytokines, and costimulation through ICOS (show CTLA4 Antibodies) and several other molecules. (Review)
The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal POZ domain. This protein acts as a sequence-specific repressor of transcription, and has been shown to modulate the transcription of START-dependent IL-4 responses of B cells. This protein can interact with a variety of POZ-containing proteins that function as transcription corepressors. This gene is found to be frequently translocated and hypermutated in diffuse large-cell lymphoma (DLCL), and may be involved in the pathogenesis of DLCL. Alternatively spliced transcript variants encoding different protein isoforms have been found for this gene.
B-cell CLL/lymphoma 6
, B-cell CLL/lymphoma 6 (zinc finger protein 51)
, B-cell lymphoma 6 protein
, zinc finger protein 51
, B-cell leukemia/lymphoma 5
, B-cell leukemia/lymphoma 6
, B-cell lymphoma 6 protein homolog
, B-cell lymphoma 5 protein
, B-cell lymphoma 6 protein transcript
, cys-his2 zinc finger transcription factor
, lymphoma-associated zinc finger gene on chromosome 3
, protein LAZ-3
, zinc finger and BTB domain-containing protein 27
, zinc finger transcription factor BCL6S